Evidence map›Paper›PMID 37276931›Full record

ArticleJournal of the American Academy of Dermatology2024

Drug reaction eosinophilia and systemic symptoms: Clinical phenotypic patterns according to causative drug.

Kimberly G Blumenthal, Santiago Alvarez-Arango, Daniela Kroshinsky, Ying-Chih Lo, Upeka Samarakoon, Abigail Rose Salem, Xiaoqing Fu, Fatima Bassir, Liqin Wang, Jordon Jaggers and 2 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the American Academy of Dermatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Kimberly G BlumenthalDivision of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: kblumenthal@mgh.harvard.edu.
Santiago Alvarez-ArangoDivision of Clinical Pharmacology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland; Division of Allergy and Clinical Immunology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Daniela KroshinskyDepartment of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
Ying-Chih LoHarvard Medical School, Boston, Massachusetts; Division of General Internal Medicine and Primary Care, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Upeka SamarakoonDivision of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts.
Abigail Rose SalemDivision of General Internal Medicine and Primary Care, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Xiaoqing FuDivision of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts.
Fatima BassirDivision of General Internal Medicine and Primary Care, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Liqin WangDivision of General Internal Medicine and Primary Care, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Jordon JaggersDepartment of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
Elizabeth PhillipsDepartment of Medicine, Center for Drug Safety and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee; Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Australia.
Li ZhouHarvard Medical School, Boston, Massachusetts; Division of General Internal Medicine and Primary Care, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

Funding

Institutional Career Development CoreKL2TR003099 · NCATS · JOHNS HOPKINS UNIVERSITY · PI GEBO, KELLY A · 2019 to 2023
$7.9M
Clinical Informatics to Advance Epidemiology and Pharmacogenetics of Serious Cutaneous Adverse Drug ReactionsR01AI150295 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI ZHOU, LI · 2019 to 2022
$2.8M
NCATS NIH HHS KL2 TR003099NIAID NIH HHS R01 AI150295
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug Hypersensitivity SyndromePhenotypeAdultAgedEosinophiliaFemaleHumansMaleMiddle Agedbeta-lactamDIHSDRESSdrug-induced hypersensitivity syndromedrug reaction with eosinophilia and systemic symptomsepidemiologypharmacoepidemiologySCARsevere cutaneous adverse reactionvancomycin

Identifiers

PMID37276931
PMCPMC11285528

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.